Portfolio
Approach
News
Who We Are
Careers
Portfolio
Approach
News
Fellowship
Who We Are
Careers
Contact
Qiming China
News
Cutting Edge
Lastest News
Categories
Portfolio Company
Search
January 13, 2021
Jasper Therapeutics and Graphite Bio Announce Collaboration to Evaluate JSP191 as Conditioning…
Portfolio Company
January 09, 2021
Korro Bio to Present at J.P. Morgan Healthcare Conference
Portfolio Company
January 09, 2021
Talaris Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Portfolio Company
December 18, 2020
Amphivena Therapeutics Announces First Patient Dosed in the Phase 1 Dose Expansion of AMV564
Portfolio Company
December 17, 2020
Cadent Therapeutics Enters Agreement to be Acquired by Novartis
Portfolio Company
December 08, 2020
Jasper Therapeutics Announces Data from First Transplant-naive Patient in Phase 1 Clinical Trial of JSP191 as Conditioning Agent in Patients with SCID Undergoing Hematopoietic Cell Transplantation
Portfolio Company
Load More
